Desarrollo y Teratología del Sistema Nervioso Central y Órganos de los Sentidos. Neurogénesis. Neurorregeneración.
![Foto de Desarrollo y Teratología del Sistema Nervioso Central y Órganos de los Sentidos. Neurogénesis. Neurorregeneración.](/img/uploaded/4C1320636337A52F5891CAA0FC259BD6.png)
![Foto de Mutua de Terrassa](/img/noimage_org.png)
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (8)
2022
-
A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype
Frontiers in Cardiovascular Medicine, Vol. 9
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome
Stroke, Vol. 52, Núm. 1, pp. 132-141
2020
-
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
Scientific Reports, Vol. 10, Núm. 1
2019
-
Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients
Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164
2017
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
2014
-
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial
The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460